Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Mar 5;15(7):392–397. doi: 10.1016/j.clml.2015.02.021

Figure 1.

Figure 1

Kaplan-Meier curve depicting time to progression in patients receiving P276-00, limited to patients included in the pre-defined efficacy population (n = 9).